The Company has enclosed herewith RTA Report on re-lodgement of transfer of physical shares upto 31.08.2025.
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Krebs Biochemicals has submitted a Registrar and Transfer Agent (RTA) report to the exchanges regarding the re-lodgement of physical share transfers. The report covers re-lodgement activity up to August 31, 2025. This is a routine compliance filing related to the processing of physical share transfer requests submitted by shareholders. The company has enclosed the RTA report as required under SEBI's framework for physical share transfers. No new financial figures, dividend, or business update is mentioned in this filing.
This is a routine regulatory disclosure with no material impact on the stock price or shareholder value. Investors holding shares in physical form should ensure timely re-lodgement of any pending transfer requests before applicable deadlines.